Home > Insider Trading > Merck & Co. Inc. > Profile

Merck & Co. Inc. (MRK)

Sector: Pharmaceutical Preparations

Related Insiders

Ellen Mary Coe, Director, 2022-01-04
H Thomas Glocer, Director, 2022-01-04
E Christine Seidman, Director, 2022-01-04

Ellen Mary Coe, Director, 2022-01-04
H Thomas Glocer, Director, 2022-01-04
E Christine Seidman, Director, 2022-01-04
C Peter Wendell, Director, 2022-01-04
C Kenneth Frazier, Executive Chair, 2021-11-10
R. Richard Deluca, Evp&pres, Merck Animal Heallth, 2021-11-05
Caroline Litchfield, Evp & Cfo, 2021-11-05
Frank Clyburn, Evp & Pres ? Human Health, 2021-11-04
A Rita Karachun, Sr. Vp Fince-Global Controller, 2021-11-04
L. Julie Gerberding, Evp, Chief Patient Officer, 2021-11-03
Sanat Chattopadhyay, Exe V-P & Pres. Mmd, 2021-11-02
Steven Mizell, Evp, Chief Hr Officer, 2021-11-02
N Cristal Downing, Chief Comm. & Public Afrs Ofcr, 2021-08-25
A Michael Klobuchar, Evp - Chief Strategy Officer, 2021-07-15
F Patricia Russo, Director, 2021-06-02
J Kathy Warden, Director, 2021-06-02
G Inge Thulin, Director, 2021-06-02
Paul Rothman, Director, 2021-06-02
Stephen Mayo, Director, 2021-06-02
J Risa Lavizzo-Mourey, Director, 2021-06-02
J. Pamela Craig, Director, 2021-06-02
A Leslie Brun, Director, 2021-06-02
M Robert Davis, President, 2021-05-06
Lisa Lecointe-Cephas, Svp Chief Ethics & Com Officer, 2021-05-06
Y Dean Li, Executive Vp & President, Mrl, 2021-05-06
Michael David Williams, Evp,chief Info&digital Officer, 2021-05-06
Jennifer Zachary, Evp, General Counsel, 2021-05-06
Michael Nally, Evp, Chief Marketing Officer, 2021-03-02
Michael Fleming, Svp Chief Ethics & Com Officer, 2021-03-02
R Thomas Cech, Director, 2020-06-02
P Wendell Weeks, Director, 2020-05-07
M Roger Perlmutter, Exe V-P & Pres, Mrl, 2020-05-05
B Rochelle Lazarus, Director, 2020-04-02
H James Scholefield, Evp,chief Info&digital Officer, 2019-11-01
H John Noseworthy, Director, 2019-04-02
H Adam Schechter, Evp & Pres-Global Human Health, 2018-11-02
Ashley Watson, Svp Chief Ethics & Com Officer, 2018-11-01
B. Craig Thompson, Director, 2018-05-29
M Mirian Weir Graddick, Exe V-P, Hr, 2018-05-08
J Michael Holston, Evp, General Counsel, 2018-03-02
D Adele Ambrose, Sr.v-P & Chief Comuns Officer, 2017-09-06
E Carlos Represas, Director, 2017-05-30
Robert C Kidder, Director, 2017-05-12
Clark Golestani, Evp & Chief Info Officer, 2016-08-10
Michael Rosenblatt, Exec V-P & Chief Med Officer, 2016-05-12
Jr B William Harrison, Director, 2016-04-13
A Willie Deese, Exe V-P & Pres. Mmd, 2016-02-24
N Bruce Kuhlik, Exe V-P & Gen Counsel, 2015-05-05
P Bridgette Heller, Exe.vp & Pres.con.hlth.care, 2014-05-13
John Canan, Sr.v-P Finc-Global Controller, 2014-02-26
N Peter Kellogg, Exe V-P & Cfo, 2014-02-26
V Cuong Do, Evp & Chief Strategy Officer, 2013-05-08
S Peter Kim, Exe V-P & Pres, Mrl, 2013-02-27
Iii S Richard Bowles, Exe Vp&chief Ethics & Comploff, 2012-05-10
Chris J Scalet, Exe V-P Global Srvs & Cio, 2012-05-04
M Anne Tatlock, Director, 2012-04-03
N Willam Kelley, Director, 2012-04-03
F Steven Goldstone, Director, 2012-04-03
E Raul Kohan, Exe Vice President, 2012-01-04
E Thomas Shenk, Director, 2011-05-31
R Harry Jacobson, Director, 2011-05-31
Mervyn Turner, Chief Strategy Officer, 2011-03-01
T Richard Clark, Chairman, 2011-03-01
F Stanley Barshay, Exvp&presconshlthcare, 2010-03-05
Md O Samuel Thier, Director, 2009-11-05
R Eugene Mcgrath, Director, 2009-11-04
J Thomas Colligan, Director, 2009-11-04
F Arthur Weinbach, Director, 2009-11-04
L Jack Stahl, Director, 2009-11-04
L Brent Saunders, Officer, 2009-11-04
C Kathryn Turner, Director, 2009-11-04
Jr J Thomas Sabatino, Officer, 2009-11-04
Fw Robert Oordt Van, Director, 2009-11-04
Smith Carrie Cox, Officer, 2009-11-04
H Steven Koehler, Officer, 2009-11-04
P Thomas Koestler, Officer, 2009-11-04
Fred Hassan, Officer, Director, 2009-11-04
J Robert Bertolini, Officer, 2009-11-04
Ron C Cheeley, Officer, 2009-11-04
Jr E Carl Mundy, Director, 2009-06-02

Show All Insiders (80)

Hedge Fund Popularity

Display

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on January 19, 2022, 5:15 pm based on SEC 13F filings Last update: January 19, 2022, 5:15 pm

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm	77,934	$5,973	+1%	2.26%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Frazier	$31.77	12,236	Officer, Director	192,520	2011-08-15	Filing
Frazier	$31.78	19,764	Officer, Director	180,284	2011-08-15	Filing
Kellogg	$31.80	200	Officer	53,999	2011-08-12	Filing
Kellogg	$31.77	1,635	Officer	53,799	2011-08-12	Filing
Kellogg	$31.80	4,000	Officer	52,164	2011-08-12	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Frazier	$83.23	29,615	Officer, Director	586,795	2021-11-09	Filing
Frazier	$82.22	634,266	Officer, Director	616,410	2021-11-09	Filing
Deluca	$90.40	29,782	Officer	116,930	2021-11-04	Filing
Litchfield	$91.00	18,335	Officer	24,114	2021-11-04	Filing
Karachun	$88.45	25,000	Officer	35,799	2021-11-03	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Dnb Asset Management As	652,592	$50,014,651	0.29%
2.	Sarasin & Partners Llp	4,074,221	$312,248	2.84%
3.	Sara-bay Financial	3,347	$257,000	0.07%
4.	Royal London Asset Management Ltd	878,952	$67,367	0.26%
5.	Value Partner Investments Inc.	796,019	$60,788	4.93%

News See All

Click here to See All News